This article is included in these additional categories: Contracts - Awards | Medical | Other Corporation | USA
Up to $58M for Flu Pills
For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
If you are already a subscriber, login to your account.
Roche Laboratories Inc. in Nutley, NJ received a maximum $58 million firm-fixed-price contract for Army, Navy, Air Force, and Marine Corps for Oseltamivir Phosphate Capsules. The drug is more popularly known as TAMIFLU, and it is often prescribed in America for the treatment and prevention of influenza. This is a requirements contract with a base year and one option period; the base year expires Feb. 28, 2006. There were two proposals solicited and one responded. The Defense Supply Center Philadelphia in Philadelphia, PA issued the contract (SP0200-05-D-0009).
One Source: Hundreds of programs; Thousands of links, photos, and analyses
DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.
Benefits
- Save time
- Eliminate your blind spots
- Get the big picture, quickly
- Keep up with the important facts
- Stay on top of your projects or your competitors
Features
- Coverage of procurement and doctrine issues
- Timeline of past and future program events
- Comprehensive links to other useful resources
Monthly
$59.95/Per Month
- Charged Monthly
- 1 User
Quarterly
$50/Per Month
- $150 Charged Each Quarter
- 1 User
Yearly
$45/Per Month
- $540 charged each year
- 1 User
2 years
$35/Per Month
- $840 Charged every other year
- 1 User